Seiki et al16have reported that the expression levels of TPO increased in MDS patients and showed differences in different groups, confirming that increased plasma TPO levels were associated with a favorable prognosis of bone marrow failure. This evidence concerns the gene TPO and Bone marrow hypocellularity.